argus

JUBILANT PHARMOVA LIMITED

NSE: JUBLPHARMAINE700A0103314,422 Cr

Timeline

Time (IST)TypeMEventSrc
22 May, 02:50 pmJubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Change in Managementbse
22 May, 02:41 pmJubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Change in Directoratebse
22 May, 02:40 pmJubilant Pharmova Limited has informed the Exchange regarding Outcome of Board Meeting held on May 22, 2026.nse
22 May, 02:40 pmJubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Change in Managementbse
22 May, 02:39 pmJubilant Pharmova Limited has informed the Exchange regarding Outcome of Board Meeting held on May 22, 2026.nse
22 May, 02:32 pmJubilant Pharmova Limited has informed the Exchange that Record date for the purpose of DI is 24-Jul-2026.nse
22 May, 02:31 pmJubilant Pharmova Ltd - 530019 - Corporate Action-Board approves Dividendbse
22 May, 02:30 pmJubilant Pharmova Limited has informed the Exchange that Board of Directors at its meeting held on May 22, 2026, recommended Final Dividend of Rs. 5 per equity share.nse
22 May, 02:30 pmJubilant Pharmova Ltd - 530019 - Audited Financial Results For The Quarter And Year Ended March 31., 2026bse
22 May, 02:28 pmJubilant Pharmova Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.nse
24 Apr, 06:51 pmJubilant Pharmova Ltd - 530019 - Board Meeting Intimation for Meeting Held On May 22, 2026bse
13 Apr, 06:11 pmHari Shanker Bharti Family Trust has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.nse
30 Mar, 08:02 pmJubilant Pharmova Limited has informed the Exchange regarding 'Submission of communication sent to shareholders relating to notice of transfer of equity shares / dividend to Investor Education and Protection Fund Authority '.nse
13 Feb, 11:10 pmJubilant Pharmova Limited has informed the Exchange about General Updatesnse
13 Feb, 10:59 pmJubilant Pharmova Ltd - 530019 - USFDA Communication Montreal, Canadabse
06 Feb, 12:49 pmJubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
06 Feb, 12:48 pmJubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".nse
06 Feb, 12:44 pmJubilant Pharmova Ltd - 530019 - Un-Audited Financial Results For Quarter And Nine Months Ended December 31, 2025bse
06 Feb, 12:40 pmJubilant Pharmova Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.nse
06 Feb, 12:39 pmJubilant Pharmova Ltd - 530019 - Board Meeting Outcome for Meeting Held On February 06, 2026bse
22 Jan, 05:36 pmJubilant Pharmova Ltd - 530019 - Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2025bse
02 Jan, 06:18 pmJubilant Pharmova Limited has informed the Exchange regarding 'Special Window for Re-lodgement of Transfer Requests of Physical Shares '.nse
31 Dec, 12:56 pmJubilant Pharmova Limited has informed the Exchange about General Updatesnse
31 Dec, 12:53 pmJubilant Pharmova Ltd - 530019 - Order Received From The Income Tax Departmentbse
30 Dec, 05:49 pmJubilant Pharmova Limited has informed the Exchange about Acquisitionnse
30 Dec, 05:46 pmJubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Acquisitionbse
27 Dec, 12:08 pmJubilant Pharmova Limited has informed the Exchange regarding 'Jubilant Generics Limited - Order passed by the Assistant Commissioner Central GST Division, Roorkee'.nse
25 Dec, 06:52 pmJubilant Pharmova Limited has informed the Exchange about Delay/default in the payment of fines/penalties/dues etc. to authoritynse
25 Dec, 06:48 pmJubilant Pharmova Ltd - 530019 - Jubilant Biosys Limited, Wholly-Owned Subsidiary Of The Company Has Received An Order Passed By The Joint Commissioner Confirming Demand Of GST, Penalty And Interest For The Three Financial Years 2020-21, 2021-22 And 2022-23bse
09 Dec, 06:50 pmJubilant Pharmova Limited has informed the Exchange regarding 'updates'.nse
05 Dec, 04:48 pmJubilant Pharmova Limited has informed the Exchange about General Updatesnse
05 Dec, 04:46 pmJubilant Pharmova Ltd - 530019 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015- Receipt Of Adjudication Order_GSTbse
02 Dec, 05:28 pmJubilant Pharmova Limited has informed the Exchange about General Updatesnse
02 Dec, 05:24 pmJubilant Pharmova Ltd - 530019 - Report On Special Window For Re-Lodgement Of Transfer Requests Of Physical Sharesbse
02 Dec, 08:45 amJubilant Pharmova Limited has informed the Exchange about General Updatesnse
02 Dec, 07:33 amJubilant Pharmova Ltd - 530019 - Appointment Of Mr. Daniel J. O'Connor As CEO Of Jubilant Therapeutics Inc.bse
08 Nov, 11:25 pmJubilant Pharmova Ltd - 530019 - Submission Of Communication Email Sent To Shareholders Whose Dividend(S) Remains Unpaid Pursuant To "Saksham Niveshak - 100 Days Campaign"bse
08 Nov, 11:20 pmJubilant Pharmova Limited has informed the Exchange about General Updatesnse
04 Nov, 08:10 pmJubilant Pharmova Ltd - 530019 - USFDA Communication Montreal, Canadabse
04 Nov, 08:06 pmJubilant Pharmova Limited has informed the Exchange about General Updatesnse
31 Oct, 01:11 pmJubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
31 Oct, 01:10 pmJubilant Pharmova Limited has informed the Exchange regarding a press release dated October 31, 2025, titled "The Company has informed the Exchange regarding a press release dated October 31, 2025".nse
31 Oct, 01:05 pmJubilant Pharmova Ltd - 530019 - Un-Audited Standalone & Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2025bse
31 Oct, 01:05 pmJubilant Pharmova Limited has informed the Exchange about General Updates - Grant of Stock Options / RSUsnse
31 Oct, 01:03 pmJubilant Pharmova Limited has informed the Exchange regarding Outcome of Board Meeting held on October 31, 2025. - Grant of Stock Options / RSUsnse
31 Oct, 01:01 pmJubilant Pharmova Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.nse
27 Oct, 05:53 pmJubilant Pharmova Limited has informed the Exchange about General Updatesnse
27 Oct, 05:49 pmJubilant Pharmova Ltd - 530019 - Letter To Shareholders Whose KYC Is Not Updatedbse
14 Oct, 07:10 pmJubilant Pharmova Ltd - 530019 - Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2025bse
10 Oct, 08:00 amJubilant Pharmova Limited has informed the Exchange about General Updates - Press Release pertaining to the launch of New High-Speed Isolator based Line, at its Spokane Manufacturing Facility in the US by Jubilant HollisterStier LLC, USA, a wholly-owned subsidiary of the Companynse